Bolivia’s drug regulator has registered Russia’s pioneering Sputnik V vaccine for emergency use on the basis of the Russian Phase III trial data, the Russian Direct Investment Fund (RDIF) has said.
The jab was approved by the State Agency for Medicines and Health Technologies (AGEMED) under the emergency use authorization procedure.
Continue reading https://on.rt.com/ayuv